KCS Wealth Advisory’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,454
Closed -$320K 148
2022
Q2
$320K Sell
3,454
-211
-6% -$20.6K 0.14% 120
2022
Q1
$371K Sell
3,665
-138
-4% -$14.5K 0.17% 116
2021
Q4
$392K Buy
3,803
+15
+0.4% +$1.39K 0.16% 127
2021
Q3
$321K Sell
3,788
-289
-7% -$24.2K 0.15% 118
2021
Q2
$340K Sell
4,077
-76
-2% -$6.22K 0.16% 123
2021
Q1
$312K Buy
4,153
+575
+16% +$41.9K 0.16% 124
2020
Q4
$244K Sell
3,578
-44
-1% -$2.86K 0.16% 130
2020
Q3
$212K Sell
3,622
-1,329
-27% -$82.7K 0.17% 130
2020
Q2
$322K Sell
4,951
-260
-5% -$16.4K 0.27% 115
2020
Q1
$309K Sell
5,211
-406
-7% -$27.1K 0.31% 105
2019
Q4
$417K Sell
5,617
-569
-9% -$40K 0.31% 109
2019
Q3
$390K Sell
6,186
-54
-0.9% -$3.2K 0.27% 115
2019
Q2
$340K Sell
6,240
-85
-1% -$4.58K 0.27% 118
2019
Q1
$341K Sell
6,325
-286
-4% -$17.7K 0.3% 117
2018
Q4
$433K Buy
6,611
+349
+6% +$26.1K 0.46% 97
2018
Q3
$493K Buy
6,262
+20
+0.3% +$1.43K 0.46% 95
2018
Q2
$402K Buy
6,242
+18
+0.3% +$1.19K 0.37% 105
2018
Q1
$387K Buy
6,224
+1,333
+27% +$95.6K 0.35% 112
2017
Q4
$355K Buy
+4,891
New +$356K 0.34% 112

Other funds holding CVS

KCS Wealth Advisory's CVS Position: Q3 2022 in Review

KCS Wealth Advisory sold out of CVS Health (CVS) in Q3 2022, closing a stake of 3,454 shares — an estimated $320K sold.

KCS Wealth Advisory first reported a position in CVS in Q4 2017 and held it in 19 quarters. The position peaked at $493K in Q3 2018. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • KCS Wealth Advisory reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
  • KCS Wealth Advisory sold 3,454 CVS Health shares in Q3 2022, an estimated $320K.
  • KCS Wealth Advisory first reported a position in CVS Health in Q4 2017 and held it in 19 quarters.
  • KCS Wealth Advisory's CVS Health position peaked at $493K in Q3 2018.
  • 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on KCS Wealth Advisory's 13F filing for Q3 2022, filed 21 Oct 2022.